Currently there is a pause on clinical research in the US and it is uncertain when this pause will be lifted.
research in the US: Currently there is a... - Cure Parkinson's
research in the US
Sounds like this new ban is going to be a major setback to PD research and many other diseases.
Here are several relevant quotes from the article :
' US health agency employees are now banned from nearly all travel and certain agencies and programs have been ordered to stop issuing new contracts and grants until further notice. '
' Employees of the 13 agencies overseen by US Health and Human Services (HHS) may only travel to return from assignments or to escape life-threatening situations. That means regular meetings with state and local health officials, training sessions and grant reviews are now on hold. '
' All federal agencies have been ordered to stop funding for foreign projects, including global health, and to stop work immediately on any programs involving the World Health Organization. Some agencies have also been ordered to stop cutting checks for projects and programs. '
' Most staff members have experienced administration transitions under Democratic and Republican presidents before, but this transition has signaled “a dramatic shift” in the second Trump administration’s approach to federal agencies, especially those working on health and science, the employee said. '
' Halting vital response efforts and research, even temporarily, could take years to undo, the employee added. '
Art
Sounds like a good reason for pharma companies to set up research and gain approval in Europe. Traditionally, USA companies in particular, licence first in the US and then roll out to other markets - because the USA is the biggest market.
But Europe is a decent chunky market, and better to get your trials done there, and start earning some revenue there while your patent clock ticks down, than sit on your hands in the USA
Recently in the US a law was passed with encouragement by MJFox organization and other Parkinson's organizations with the idea it would improve collaboration on research and the name of the law is:
the National Plan to End Parkinson's Act
It is hard to know how budget cuts will impact progress in this area at this point but since it sounds like there will be a significant reduction in staff it seems likely that this is not likely to be beneficial to accomplishing the goals of this new law.